Oncology News

Expansions include a three-story critical-care center and emergency department, plus cancer treatment services in the Stanford Emanuel Radiation Oncology Center.

ZIOPHARM Oncology, Inc. , a biopharmaceutical company focused on the development and commercialization of new cancer therapies, and Solasia Pharma K.K. , a developer of oncology pharmaceuticals in-licensed for commercialization in major markets throughout the world, announced today an amendment and restatement of their License and Collaboration ... (more)

AstraZeneca announced that they will co-fund a study to be conducted by Kyowa Hakko Kirin that will test two separate combinations of three experimental compounds in the hopes of developing safe and effective immuno-oncology treatments.

She's a six-year-old gray and white pit bull with the sweetest disposition, but something went terribly wrong with her health just seven short months ago.

After several months of not knowing whether the Wichita Community Clinical Oncology Program would receive federal funds to continue clinical trials locally, program officials received word Friday morning that they will be funded.

A new clinic at Mercy Hospital Cadillac aims to make a breast cancer diagnosis and follow-up treatment faster, easier and more comfortable for women.

Dr. Herbst of Yale Cancer Center will receive the award at the 15th International Lung Cancer Congress being held on "Dr. Herbst's contribution and dedication to lung cancer treatment and research is truly remarkable and we are thrilled to present him with the Addario Lectureship Award this year," said Each year the ALCF recognizes one special ... (more)

Loxo Oncology, Inc. , a biopharmaceutical company focused on developing targeted cancer therapies for genetically-defined populations, announced the pricing of its initial public offering of 5,261,538 shares of its common stock at a price to the public of $13.00 per share.

Sorrento Therapeutics, Inc. today announced the death of Mr. Amar Singh, Chief Business Officer and Executive Vice President.

HOPEWELL TOWNSHIP - When producers at Good Morning America asked news anchor Amy Robach to undergo her first mammogram in October on live television, her first reaction was, "'Are you kidding me? You want me to do what? There is no way,'" she said.

Bob Hugin, chief executive officer of Celgene Corp., reported second-quarter results of $748 million in net income.

As rates of other cancers have declined, rates of the deadliest form of skin cancer, melanoma, have increased more than 200 percent from 1973 to 2011, according to a new "Call to Action" report from the Surgeon General's Office.

AstraZeneca turned over $6.45 billion in the second quarter, up 4%, making half year sales 3% higher than the previous year.

Use of electroacupuncture - a form of acupuncture where a small electric current is passed between pairs of acupuncture needles - produces significant improvements in fatigue, anxiety and depression in as little as eight weeks for early stage breast cancer patients experiencing joint pain related to the use of aromatase inhibitors to treat breast ... (more)

Former England and Newcastle United manager Sir Bobby Robson launches The Sir Bobby Robson Foundation in Newcastle with Dr Ruth Plummer and Bob Wilson on March 25, 2008 FACING CANCER for the fifth - and what he knew would be the final time - Sir Bobby Robson focused on a new goal far removed from the football field.

Julie Szasz with her daughter Eva at their home in St-Lazare. Szasz was diagnosed with breast cancer in 2010 that spread to her bones, but is in remission now.

Cold Genesys, Inc. , a clinical-stage biopharmaceutical company developing oncolytic immunotherapies for cancer, announced today that it has secured Series A financing of $13.57 million from Ally Bridge Group.

This past April, just after the Centers for Medicare & Medicaid Services released the highly-anticipated 2012 Medicare provider charge data, the New York Times published an article," Sliver of Medicare Doctors Get Big Share of Payout ."

AstraZeneca today announced that it has entered into a clinical study collaboration with Kyowa Hakko Kirin for a Phase I/Ib immuno-oncology study that will evaluate the safety and efficacy of two separate combinations of three investigational compounds in multiple solid tumours.

The best way to cure most cases of cancer is to surgically remove the tumor. The Achilles heel of this approach, however, is that the surgeon may fail to extract the entire tumor, leading to a local recurrence.